🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
This is a study to compare the similarity in Pharmacokinetics (PK) profile ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-03
Trial ID
NCT07601620
Treatments Being Tested
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is a randomized, open label Phase II neoadjuvant study comparing the e...
Status
Unknown
Location
ShengJing ospital of China Medical University
Start Date
2021-10-20
Trial ID
NCT05483439
This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2014-02-18
Trial ID
NCT02003209
compare the efficacy and safety of TCbHP and EC-THP regimen in HER2-positiv...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2023-06-07
Trial ID
NCT05883852
Treatments Being Tested